Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Jul 13, 2015 (11 years ago)

Intermezzo

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed dissolution specifications

Cause type: Dissolution failure

The tablet or capsule did not dissolve within specification. Dissolution controls how much drug the body absorbs; a failure can change the effective dose. All dissolution failure recalls.

What was recalled

Intermezzo (zolpidem tartrate), sublingual tablet 3.5 mg, 1 tablet per pouch, 30 pouches per carton, Rx only, Distributed by Purdue Pharma L.P. Stamford, CT 06901-3431, NDC 59011-265-30

Affected NDC 59011-0265-30

Compare with the code on your package — it is the most precise check available.

Drug: Zolpidem

Recalling firm
Purdue Pharma L.P.
NDC code
59011-265-30
Origin
CT, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1278-2015 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Zolpidem recalls

See all
Class II · Moderate risk

Zolpidem Tartrate Tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation Wockhardt Usa Inc. D-1262-2015

Other recalls by Purdue Pharma L.P.

All 2015 recalls